-Reuters
All Focus Shifts To Bionomics’ PTSD Study After Anxiety Trial Disappoints
Bionomics Limited (NASDAQ:BNOX) announced results from its Phase PREVAIL study of BNC210 for the acute treatment of Social Anxiety…
Fed’s Rosengren Says Study Released In Early July Will Indicate There Is Technology To Create A Central Bank Digital Currency In A Secure Way
-Reuters
Related Posts
United Bancshares Says Co To Voluntarily Delist From NASDAQ
United Bancshares, Inc. (the “Company”) (NASDAQ:UBOH), the holding company parent of The Union Bank Company (the “Bank”), an Ohio-chartered commercial bank headquartered in Columbus Grove, Ohio,
Needham Maintains Buy on Trulieve Cannabis, Lowers Price Target to $50
Needham analyst Matt McGinley maintains Trulieve Cannabis (OTC:TCNNF) with a Buy and lowers the price target from $54 to $50.
Deutsche Bank Maintains Buy on Regency Centers, Lowers Price Target to $69
Deutsche Bank analyst Derek Johnston maintains Regency Centers (NASDAQ:REG) with a Buy and lowers the price target from $72 to $69.